Last reviewed · How we verify
Follicular lymphoma
Approved treatments
- Intron A · Merck & Co.
- Mabthera · Roche
- Tazverik · Epizyme Inc
Tazverik works by blocking the action of the EED protein, which is involved in the regulation of gene expression. - Revlimid · Bristol-Myers Squibb
Lenalidomide targets cereblon to degrade substrate proteins, inducing cytotoxicity and immunomodulation. - Mabthera · Roche
Monoclonal antibody targeting CD20 on B-lymphocytes, mediating cell lysis via CDC and ADCC. - Mabthera · Roche
Mabthera works by binding to the CD20 antigen on B-lymphocytes, triggering their destruction. - Tazverik · Epizyme Inc
Tazverik works by blocking the action of an enzyme called EED, which is involved in the production of proteins that promote cancer growth. - Aliqopa · Bayer
- Lenali · Singapore General Hospital
- Tazverik · Edwin Posadas, MD
- Revlimid · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Follicular lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Follicular lymphoma treatment landscape brief
- Follicular lymphoma treatment updates RSS
Frequently asked questions about Follicular lymphoma
What drugs treat Follicular lymphoma?
Tracked treatments include Intron A, Mabthera, Tazverik, Revlimid, Aliqopa, Lenali.
What is the treatment for Follicular lymphoma?
Standard treatment for Follicular lymphoma includes Intron A, Mabthera, Tazverik, Revlimid, Aliqopa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Follicular lymphoma patent cliff · Follicular lymphoma CI report
- Treatment: Intron A · Merck & Co.
- Treatment: Mabthera · Roche
- Treatment: Tazverik · Epizyme Inc
- Treatment: Revlimid · Bristol-Myers Squibb
- Treatment: Mabthera · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing